Picoquant invests in Fluobrick Solutions to simplify access to single molecule research

▤ Summary

PicoQuant has invested in FluoBrick Solutions, a Berlin startup that helps researchers access single-molecule techniques more easily. FluoBrick’s first product, the Brick, supports FCS and FRET workflows and aims to reduce the expertise, sample, and time needed for advanced fluorescence experiments. The company targets academic and pharma diagnostics users who need simpler access to high-sensitivity molecular analysis. The partnership also reinforces PicoQuant’s broader strategy of making advanced fluorescence technology more accessible to scientific users.

$ Funding

▦ Linked Companies